TheracosBio Revenue and Competitors
Estimated Revenue & Valuation
- TheracosBio's estimated annual revenue is currently $1.1M per year.
- TheracosBio's estimated revenue per employee is $100,500
Employee Data
- TheracosBio has 11 Employees.
- TheracosBio grew their employee count by -8% last year.
TheracosBio's People
| Name | Title | Email/Phone |
|---|
TheracosBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is TheracosBio?
TheracosBio is a pharmaceutical company located in Marlborough, Massachusetts. TheracosBio discovers, develops and commercializes medicines for important diseases. TheracosBio believes that affordable medications for prevalent conditions may lead to more rapid advances in public health.TheracosBio has gained FDA approval of its proprietary medicine Brenzavvy™ (bexagliflozin). Press release: https://bit.ly/3HtSZ6y
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.1M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 11 | 0% | N/A |
#2 | $0.8M | 11 | 0% | $21.5M |
#3 | $1.7M | 11 | -45% | N/A |
#4 | $1M | 11 | 0% | N/A |
#5 | $1M | 11 | -8% | N/A |
